Morgan Stanley Nutri Band Inc. Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Nutri Band Inc. stock. As of the latest transaction made, Morgan Stanley holds 3,500 shares of NTRB stock, worth $25,480. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,500

Previous 3,549 1.38%

Holding current value

$25,480

Previous $21,000 28.57%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	SELL	$4.72 - $8.18 $231 - $400	-49 Reduced 1.38%	3,500 $27,000
Q1 2025 May 15, 2025	BUY	$4.07 - $9.39 $14,444 - $33,325	3,549 New	3,549 $21,000
Q2 2024 May 14, 2025	BUY	$3.35 - $6.16 $10,720 - $19,712	3,200 New	3,200 $17,000
Q2 2024 Aug 14, 2024	BUY	$3.35 - $6.16 $10,720 - $19,712	3,200 New	3,200 $17,000
Q4 2022 Feb 14, 2023	BUY	$3.53 - $4.5 $1,637 - $2,088	464 New	464 $1,000
Q1 2022 May 13, 2022	SELL	$3.3 - $9.43 $16,414 - $46,904	-4,974 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.14 - $10.08 $15,618 - $50,137	4,974 New	4,974 $50,000

Others Institutions Holding NTRB

# of Institutions

Shares Held

346K

Call Options Held

Put Options Held

View Full List

About NutriBand Inc.

Ticker NTRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,803,260
Market Cap $56.8M
Description
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid the...

More about NTRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account